Krystal Biotech, Inc. (BIT:1KRYS)
Italy
· Delayed Price · Currency is EUR 119.75
-14.60 (-10.87%)
At close: Aug 11, 2025, 5:30 PM CET
Krystal Biotech Revenue
Krystal Biotech had revenue of $96.04M USD in the quarter ending June 30, 2025, with 36.65% growth. This brings the company's revenue in the last twelve months to $359.21M, up 116.08% year-over-year. In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth.
Revenue (ttm)
$359.21M
Revenue Growth
+116.08%
P/S Ratio
12.06
Revenue / Employee
$1.31M
Employees
275
Market Cap
3.69B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.82B |
| Intesa Sanpaolo | 25.58B |
| Enel SpA | 77.79B |
| Ferrari | 6.96B |
| Assicurazioni Generali | 56.77B |
| Eni S.p.A. | 87.03B |
| Leonardo S.p.a. | 18.70B |
| Poste Italiane | 13.75B |